Original Research
Published on 06 Feb 2023
Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats
in Cardiovascular Metabolism
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1005408
- 8,446 views
- 52 citations
